MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
about
The emerging role of miR-506 in cancerThe crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancerEZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathwayMicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression.Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer developmentA folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy.Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma.The Generation and Validation of a 20-Genes Model Influencing the Prognosis of Colorectal Cancer.miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in vitro and in vivo.Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.Prognostic value of microRNAs in colorectal cancer: a meta-analysis.Wnt6 contributes tumorigenesis and development of colon cancer via its effects on cell proliferation, apoptosis, cell-cycle and migration.MicroRNA-644a promotes apoptosis of hepatocellular carcinoma cells by downregulating the expression of heat shock factor 1.MicroRNA-506 suppresses invasiveness and metastasis of human hepatocellular carcinoma cells by targeting
P2860
Q26740283-187F5919-AB46-4E81-8755-F1EE26CB9CEDQ28076568-B103590C-0077-4EF9-B38E-1CB37BD1025CQ33566687-CD783F44-FEBF-4258-87B2-E6F219B87B40Q37022273-3FF31568-658F-47A6-B00A-868878166273Q37059641-6CD5DFED-6810-48DB-8BDF-C0CD6F72ACDFQ37545071-3CF9A14E-D8B6-46A5-A474-C77A9755A4C7Q37588429-28B2EEA7-C98F-465C-9C01-323F51658263Q37702331-A6A603EE-61B3-4BC7-9ED3-2F8586A975A8Q39070721-7E09145C-C31E-403A-937D-F7A6810CBD15Q39165476-1D03F3CF-9FC8-4729-9BE7-DD82CEC5FF81Q47140497-9F17430C-7AE5-4EA0-8F57-4D3176E761F2Q48333531-B27F01AB-27AE-454C-B236-960E02C96822Q49561776-CD7C8BA8-83D0-43FA-AB58-70512F9A3938Q49777893-767588DA-DCC5-4C13-8F18-C7A84DFB3BDAQ52349529-E651ECB0-FD9D-4597-99A2-61C343588D0FQ52595227-9DE44FE1-B40A-4998-A704-C902E5886FA0Q55307845-827E959A-9757-40F8-8BA5-87C62FBC25F0Q55357349-D83EB01C-CFA0-4F9D-AEA4-9061E69A17BEQ55400384-F9FBE77F-DF28-4747-AB2E-59260635D0FFQ58804590-4350D892-392D-4BFA-AAA7-9F771D602596
P2860
MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@ast
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@en
type
label
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@ast
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@en
prefLabel
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@ast
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@en
P2093
P2860
P356
P1433
P1476
MicroRNA-506 suppresses tumor ...... ly targeting the oncogene EZH2
@en
P2093
Changwei Lin
Xingsi Liang
Yangchao Wei
P2860
P304
32586-32601
P356
10.18632/ONCOTARGET.5309
P407
P50
P577
2015-10-01T00:00:00Z